Botanical species · safety record

Amomum subulatum

The EFSA Compendium of Botanicals holds 13 constituent measurements for Amomum subulatum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Amomum subulatum Roxb.

13Constituent measurements

0Safety records

8Cited sources

2Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 2 licensed products naming Amomum subulatum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Fruit extract

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	Seed	Essential oil	61.3 Percent	GC-MS	Resolve DOI
Gallic acid	Husk	Solvent extraction	27.39 Microgram/gram	HPLC-UV	Resolve DOI
Lawsone	Fruit unspecified	Drying (dehydration)	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Oxalates	Seed	Drying (dehydration)	2055 Milligram/100 gram	Unspecified	Resolve DOI
Tannic acid	Husk	Solvent extraction	10.5 Microgram/gram	HPLC-UV	Resolve DOI
1,8-cineole	Leaves	Essential oil	15.87 Percent	—	No resolvable identifier
1,8-cineole	Fruit unspecified	Essential oil	24.49 Percent	GC-MS	No resolvable identifier
1,8-cineole	Fruit unspecified	Essential oil	77.4 Percent	GC-FID	No resolvable identifier
1,8-cineole	Husk	Essential oil	73.27 Percent	GC-MS	No resolvable identifier
Camphor	Leaves	Essential oil	2.67 Percent	—	No resolvable identifier
Eugenol	Fruit unspecified	Essential oil	14.12 Percent	GC-MS	No resolvable identifier
Myrcene	Fruit unspecified	Essential oil	5 Percent	GC-FID	No resolvable identifier
Piperitone oxide	Fruit unspecified	Essential oil	6.25 Percent	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Sashidhara, K. V., Verma, R. S., Ram, P. Constituents of leaf essential oil of Amomum subulatum Roxb. from lower region of Himalayas. Indian perfumer, 2005, vol. 49, no. 2, p. 169-171.
Adegoke, GO., Rao, LJM., Shankaracharya, NB. A comparison of the essential oils of Aframomum daniellii (Hook. f.) K. Schum. and Amomum subulatum Roxb . Flavour and fragrance journal, 1998, vol. 13, no. 5, p. 349-352. DOI
Das, Sumana Ghosh., Savage, G. P. Total and Soluble Oxalate Content of Some Indian Spices. Plant foods for human nutrition, 2012, vol. 67, no. 2, p. 186-190. DOI
Ritender., Bhatt, Meenakshi., Juyal, Vijay. Chemical composition of essential oil from the fruits of Ammomum subulatum. International journal of universal pharmacy and bio sciences, 2013, vol. 2, no. 5), 531-53, p. 8 pp.
Kumar, Gopal., Chauhan, Baby., Ali, Mohammed. New alkadiene, benzyl linolenate and lawsone arabinosyl ester from the fruits of Amomum subulatum Roxb . Journal of saudi chemical society, 2016, vol. 20, p. S476-S479. DOI
Kaskoos, Raad A., Mir, Showkat R., Kapoor, Reni., Ali, Mohd. Essential oil composition of the fruits of Amomum subulatum Roxb.. Journal of essential oil bearing plants, 2008, vol. 11, no. 2, p. 184-187.
Bhandari, A. K., Bisht, V. K., Negi, J. S., Baunthiyal, M. 1,8-Cineole: a predominant component in the essential oil of large cardamom (Amomum subulatum Roxb.). Journal of medicinal plants research, 2013, vol. 7, no. 26, p. 1951-1956.
Singh, U.P., Singh, D.P., Maurya, S., Maheshwari, R., Singh, M., Dubey, R.S., Singh, R.B. Investigation on the phenolics of some spices having pharmacotherapeutic properties. Journal of herbal pharmacotherapy, 2004, vol. 4, no. 4, p. 27-42. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature